These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Discovery of potent non-urea inhibitors of soluble epoxide hydrolase. Xie Y; Liu Y; Gong G; Smith DH; Yan F; Rinderspacher A; Feng Y; Zhu Z; Li X; Deng SX; Branden L; Vidović D; Chung C; Schürer S; Morisseau C; Hammock BD; Landry DW Bioorg Med Chem Lett; 2009 Apr; 19(8):2354-9. PubMed ID: 19303288 [TBL] [Abstract][Full Text] [Related]
29. Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores. Scholz MS; Wingen LM; Brunst S; Wittmann SK; Cardoso ILA; Weizel L; Proschak E Eur J Med Chem; 2020 Jan; 185():111766. PubMed ID: 31677445 [TBL] [Abstract][Full Text] [Related]
30. Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase. Eldrup AB; Soleymanzadeh F; Farrow NA; Kukulka A; De Lombaert S Bioorg Med Chem Lett; 2010 Jan; 20(2):571-5. PubMed ID: 19969453 [TBL] [Abstract][Full Text] [Related]
31. From the Design to the Codony S; Calvó-Tusell C; Valverde E; Osuna S; Morisseau C; Loza MI; Brea J; Pérez C; Rodríguez-Franco MI; Pizarro-Delgado J; Corpas R; Griñán-Ferré C; Pallàs M; Sanfeliu C; Vázquez-Carrera M; Hammock BD; Feixas F; Vázquez S J Med Chem; 2021 May; 64(9):5429-5446. PubMed ID: 33945278 [TBL] [Abstract][Full Text] [Related]
32. Incorporation of piperazino functionality into 1,3-disubstituted urea as the tertiary pharmacophore affording potent inhibitors of soluble epoxide hydrolase with improved pharmacokinetic properties. Huang SX; Li HY; Liu JY; Morisseau C; Hammock BD; Long YQ J Med Chem; 2010 Dec; 53(23):8376-86. PubMed ID: 21070033 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides. Morisseau C; Pakhomova S; Hwang SH; Newcomer ME; Hammock BD Bioorg Med Chem Lett; 2013 Jul; 23(13):3818-21. PubMed ID: 23684894 [TBL] [Abstract][Full Text] [Related]
34. Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors. Rezaee E; Amrolah SM; Nazari M; Tabatabai SA Mol Divers; 2021 Feb; 25(1):45-53. PubMed ID: 31873869 [TBL] [Abstract][Full Text] [Related]
35. Soluble epoxide hydrolase inhibitory components from Rheum undulatum and in silico approach. Jo AR; Kim JH; Yan XT; Yang SY; Kim YH J Enzyme Inhib Med Chem; 2016; 31(sup2):70-78. PubMed ID: 27555350 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs. Tsai HJ; Hwang SH; Morisseau C; Yang J; Jones PD; Kasagami T; Kim IH; Hammock BD Eur J Pharm Sci; 2010 Jun; 40(3):222-38. PubMed ID: 20359531 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of soluble epoxide hydrolase by phytochemical constituents of the root bark of Kim JH; Park JS; Lee YJ; Choi S; Kim YH; Yang SY J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1049-1055. PubMed ID: 34000951 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase. Pecic S; Deng SX; Morisseau C; Hammock BD; Landry DW Bioorg Med Chem Lett; 2012 Jan; 22(1):601-5. PubMed ID: 22079754 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility. Kim IH; Morisseau C; Watanabe T; Hammock BD J Med Chem; 2004 Apr; 47(8):2110-22. PubMed ID: 15056008 [TBL] [Abstract][Full Text] [Related]
40. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase. Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]